NCT00480662View on ClinicalTrials.gov

A Research Study to Test the Effectiveness of MK0217 in Patients With Paget's Bone Disease (0217-206)(COMPLETED)

PHASE3CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

October 31, 2001

Primary Completion Date

October 31, 2002

Study Completion Date

October 31, 2002

Conditions
Paget's Disease of Bone
Interventions
DRUG

alendronate

Duration of Treatment : 6 Months

All Listed Sponsors
lead

Organon and Co

INDUSTRY

NCT00480662 - A Research Study to Test the Effectiveness of MK0217 in Patients With Paget's Bone Disease (0217-206)(COMPLETED) | Biotech Hunter | Biotech Hunter